메뉴 건너뛰기




Volumn 116, Issue 1, 2010, Pages 82-87

Patients' acceptance and psychometric properties of the EORTC QLQ-CX24 after surgery

Author keywords

Outcome assessment; Quality of life; Questionnaires; Uterine cervical neoplasms; Validation studies

Indexed keywords

ADULT; AGED; ANALYTICAL ERROR; ARTICLE; BODY IMAGE; CANCER SURGERY; DEMOGRAPHY; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER CERVICAL CANCER MODULE QLQ CX24; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SEXUALITY; SYMPTOM; UTERINE CERVIX CANCER; VALIDATION STUDY; VALIDITY;

EID: 70749088611     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.09.022     Document Type: Article
Times cited : (22)

References (21)
  • 1
    • 0034464743 scopus 로고    scopus 로고
    • Quality of life as an outcome measure in gynecologic malignancies
    • Anderson B., and Lutgendorf S. Quality of life as an outcome measure in gynecologic malignancies. Curr. Opin. Obstet. Gynecol. 12 (2000) 21-26
    • (2000) Curr. Opin. Obstet. Gynecol. , vol.12 , pp. 21-26
    • Anderson, B.1    Lutgendorf, S.2
  • 2
    • 0030144108 scopus 로고    scopus 로고
    • Quality of life in patients with ovarian cancer: current state of research
    • Montazeri A., McEwen J., and Gillis C.R. Quality of life in patients with ovarian cancer: current state of research. Support Care Cancer 4 (1996) 169-179
    • (1996) Support Care Cancer , vol.4 , pp. 169-179
    • Montazeri, A.1    McEwen, J.2    Gillis, C.R.3
  • 3
    • 0027417437 scopus 로고
    • The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology
    • Aaronson N., Ahmedzai S., Bergmann B., Bullinger M., Cull A., Duez N.J., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl. Cancer Inst. 85 (1993) 365-376
    • (1993) J. Natl. Cancer Inst. , vol.85 , pp. 365-376
    • Aaronson, N.1    Ahmedzai, S.2    Bergmann, B.3    Bullinger, M.4    Cull, A.5    Duez, N.J.6
  • 4
    • 0038121967 scopus 로고    scopus 로고
    • An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer
    • Greimel E., Bottomley A., Cull A., Waldenstrom A.C., Arraras J., Chauvenet L., et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur. J. Cancer 39 (2003) 1402-1408
    • (2003) Eur. J. Cancer , vol.39 , pp. 1402-1408
    • Greimel, E.1    Bottomley, A.2    Cull, A.3    Waldenstrom, A.C.4    Arraras, J.5    Chauvenet, L.6
  • 5
    • 54449096532 scopus 로고    scopus 로고
    • An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer
    • van Andel G., Bottomley A., Fossa S.D., Efficace F., Coens C., Guerif S., et al. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur. J. Cancer 44 (2008) 2418-2424
    • (2008) Eur. J. Cancer , vol.44 , pp. 2418-2424
    • van Andel, G.1    Bottomley, A.2    Fossa, S.D.3    Efficace, F.4    Coens, C.5    Guerif, S.6
  • 6
    • 33847756681 scopus 로고    scopus 로고
    • EORTC QLQ-INFO26: a questionnaire to assess information given to cancer patients a preliminary analysis in eight countries
    • Arraras J., Kuljanic-Vlasic K., Bjordal K., Yun Y.H., Efficace F., Holzner B., et al. EORTC QLQ-INFO26: a questionnaire to assess information given to cancer patients a preliminary analysis in eight countries. Psychooncology 16 (2007) 249-254
    • (2007) Psychooncology , vol.16 , pp. 249-254
    • Arraras, J.1    Kuljanic-Vlasic, K.2    Bjordal, K.3    Yun, Y.H.4    Efficace, F.5    Holzner, B.6
  • 8
    • 0032980277 scopus 로고    scopus 로고
    • Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35
    • Björdal K., Hammerlid E., Ahlner-Elmqvist M., de Graeff A., Boysen M., Evensen J.F., et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J. Clin. Oncol. 17 (1999) 1008-1019
    • (1999) J. Clin. Oncol. , vol.17 , pp. 1008-1019
    • Björdal, K.1    Hammerlid, E.2    Ahlner-Elmqvist, M.3    de Graeff, A.4    Boysen, M.5    Evensen, J.F.6
  • 11
    • 59649102208 scopus 로고    scopus 로고
    • Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire cervical cancer module
    • Shin D.W., Ahn E., Kim Y.M., Kang S., Kim B.G., Seong S.J., et al. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire cervical cancer module. Oncology 76 (2009) 190-198
    • (2009) Oncology , vol.76 , pp. 190-198
    • Shin, D.W.1    Ahn, E.2    Kim, Y.M.3    Kang, S.4    Kim, B.G.5    Seong, S.J.6
  • 12
    • 57349088719 scopus 로고    scopus 로고
    • The EORTC QLQ-CX24 cervical cancer-specific quality of life questionnaire: psychometric properties in a South Asian sample of cervical cancer patients
    • Jayasekara H., Rajapaksa L.C., and Greimel E.R. The EORTC QLQ-CX24 cervical cancer-specific quality of life questionnaire: psychometric properties in a South Asian sample of cervical cancer patients. Psychooncology 17 (2008) 1053-1057
    • (2008) Psychooncology , vol.17 , pp. 1053-1057
    • Jayasekara, H.1    Rajapaksa, L.C.2    Greimel, E.R.3
  • 13
    • 0242609694 scopus 로고    scopus 로고
    • Total mesometrial resection: high resolution nerve-sparing radical hysterectomy based on developmentally defined surgical anatomy
    • Hockel M., Horn C., Hentschel B., Hockel S., and Naumann G. Total mesometrial resection: high resolution nerve-sparing radical hysterectomy based on developmentally defined surgical anatomy. Int. J. Gynecol. Cancer 13 (2003) 791-803
    • (2003) Int. J. Gynecol. Cancer , vol.13 , pp. 791-803
    • Hockel, M.1    Horn, C.2    Hentschel, B.3    Hockel, S.4    Naumann, G.5
  • 14
    • 0020527558 scopus 로고
    • The Hospital Anxiety and Depression Scale
    • Zigmond A.S., and Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. 67 (1983) 361-370
    • (1983) Acta Psychiatr. Scand. , vol.67 , pp. 361-370
    • Zigmond, A.S.1    Snaith, R.P.2
  • 15
    • 54549102030 scopus 로고    scopus 로고
    • Primary pelvic exenteration in cervical cancer patients
    • Ungar L., Palfalvi L., and Novak Z. Primary pelvic exenteration in cervical cancer patients. Gynecol. Oncol. 111 (2008) S9-S12
    • (2008) Gynecol. Oncol. , vol.111
    • Ungar, L.1    Palfalvi, L.2    Novak, Z.3
  • 17
    • 43149103383 scopus 로고    scopus 로고
    • The impact of cervical cancer on quality of life: a personal account
    • Baze C., Monk B.J., and Herzog T.J. The impact of cervical cancer on quality of life: a personal account. Gynecol. Oncol. 109 (2008) S12-S14
    • (2008) Gynecol. Oncol. , vol.109
    • Baze, C.1    Monk, B.J.2    Herzog, T.J.3
  • 18
    • 33646392467 scopus 로고    scopus 로고
    • Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study
    • McQuellon R.P., Thaler H.T., Cella D., and Moore D.H. Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study. Gynecol. Oncol. 101 (2006) 296-304
    • (2006) Gynecol. Oncol. , vol.101 , pp. 296-304
    • McQuellon, R.P.1    Thaler, H.T.2    Cella, D.3    Moore, D.H.4
  • 19
    • 4143135504 scopus 로고    scopus 로고
    • Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
    • Moore D.H., Blessing J.A., McQuellon R.P., Thaler H.T., Cella D., Benda J., et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J. Clin. Oncol. 22 (2004) 3113-3119
    • (2004) J. Clin. Oncol. , vol.22 , pp. 3113-3119
    • Moore, D.H.1    Blessing, J.A.2    McQuellon, R.P.3    Thaler, H.T.4    Cella, D.5    Benda, J.6
  • 20
    • 32644468357 scopus 로고    scopus 로고
    • Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: a Gynecologic Oncology Group study
    • Long III H.J., Monk B.J., Huang H.Q., Grendys Jr. E.C., McMeekin D.S., Sorosky J., et al. Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: a Gynecologic Oncology Group study. Gynecol. Oncol. 100 (2006) 537-543
    • (2006) Gynecol. Oncol. , vol.100 , pp. 537-543
    • Long III, H.J.1    Monk, B.J.2    Huang, H.Q.3    Grendys Jr., E.C.4    McMeekin, D.S.5    Sorosky, J.6
  • 21
    • 23044471142 scopus 로고    scopus 로고
    • Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study
    • Monk B.J., Huang H.Q., Cella D., and Long III H.J. Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J. Clin. Oncol. 23 (2005) 4617-4625
    • (2005) J. Clin. Oncol. , vol.23 , pp. 4617-4625
    • Monk, B.J.1    Huang, H.Q.2    Cella, D.3    Long III, H.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.